SAN FRANCISCO, CALIF.—Four-year results from the SYNTAX trial show that most patients with three-vessel disease continue to derive more benefit from CABG than from PCI. But in patients with left main ...
Adding functional information to the SYNTAX score helps better identify patients with less complex three-vessel CAD who appear to benefit as much from PCI as they would from CABG surgery, according to ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- With ...
The 3-year results of the SYNTAX trial, according to data presented by Patrick W. Serruys, MD, PhD, suggested that percutaneous coronary intervention is a reasonable alternative to CABG for patients ...
(either a second PCI or bypass surgery) by the end of the first year. In its head-to-head comparison of PCI vs. bypass surgery, SYNTAX found no statistically significant difference in risk of death (4 ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In patients with unprotected left main ...
-- One-Year Data Find Angioplasty and Stenting Safe and Effective in Patients for Whom Standard Therapy Has Been Open-Heart Surgery Data announced today from the landmark SYNTAX trial indicate that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback